Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Gains from Sales and Divestitures (2016 - 2024)

Historic Gains from Sales and Divestitures for Alkermes (ALKS) over the last 13 years, with Q4 2024 value amounting to $2.2 million.

  • Alkermes' Gains from Sales and Divestitures fell 1372.68% to $2.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.2 million, marking a year-over-year decrease of 1372.68%. This contributed to the annual value of $2.2 million for FY2024, which is 1372.68% down from last year.
  • Latest data reveals that Alkermes reported Gains from Sales and Divestitures of $2.2 million as of Q4 2024, which was down 1372.68% from $2.6 million recorded in Q4 2023.
  • Alkermes' 5-year Gains from Sales and Divestitures high stood at $2.6 million for Q4 2023, and its period low was $1.1 million during Q4 2020.
  • Moreover, its 5-year median value for Gains from Sales and Divestitures was $2.1 million (2022), whereas its average is $2.0 million.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first skyrocketed by 7215.67% in 2021, then plummeted by 1372.68% in 2024.
  • Over the past 5 years, Alkermes' Gains from Sales and Divestitures (Quarter) stood at $1.1 million in 2020, then soared by 72.16% to $1.9 million in 2021, then increased by 8.63% to $2.1 million in 2022, then increased by 26.39% to $2.6 million in 2023, then fell by 13.73% to $2.2 million in 2024.
  • Its Gains from Sales and Divestitures stands at $2.2 million for Q4 2024, versus $2.6 million for Q4 2023 and $2.1 million for Q4 2022.